"Apparently, you can only be treated once": A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program
Authors: Fontaine G, Presseau J, Bruneau J, Patey AM, van Allen Z, Mortazhejri S, Høj SB, Hung JC, Grimshaw JM
Journal: Liver International
GRAND PLAN: Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment of Hepatitis C Virus Infection Among People Initially Disengaged From Health Care Who Use Drugs-A Systematic Multidisciplinary Approach
Authors: Conway, B., Yi, S., Yung, R. & Sharma, S.
Journal: Open Forum Infectious Diseases
Modeling the impact of a supervised consumption site on HIV and HCV transmission among people who inject drugs in three counties in California, USA
Authors: Bartlett SR, Schmitz D, Harnest J, Duddy J, Lee M
Journal: International Journal of Drug Policy
Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study
Authors: Passos-Castilho AM, Murphy DG, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, Klein MB, Kwong JC, Sander B, Janjua NZ, Greenaway C
Journal: Viruses
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis
Authors: Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis S, Read P, Martró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J, Vickerman P, Larney S
Journal: eClinical Medicine (PArt of Lancet Discovery Science)
The impact of the COVID-19 pandemic on social determinants of health, mental health, and substance use among key populations affected by sexually transmitted and blood-borne infections in Canada
Authors: Apelian H, Aho J, Wong E, Cox J
Journal: Canadian Journal of Public Health
Trends in toxicological findings in unintentional opioid or stimulant toxicity deaths in Québec, Canada, 2012-2021: Has Québec entered a new era of drug-related deaths
Authors: Do U, Perron PA, Bruneau J, Larney S
Journal: Drugs and Alcohol Review
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers
Authors: Fontaine G, Presseau J, Bruneau J, Etherington C, Thomas IM, Hung JC, van Allen Z, Patey AM, Kareem A, Mortazhejri S, Høj SB, Boyer-Legault G, Grimshaw JM
Journal: International Journal for Equity in Health
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada
Authors: Greenwald ZR, Werb D, Feld JJ, Austin P, Fridman D, Bayoumi AM, Gomes T, Kendall C, Lapointe-Shaw L, Scheim AI, Bartlett S, Benchimol EI, Bouck Z, Boucher L, Greenaway C, Janjua NZ, Leece P, Wong WWL, Sander B, Kwong JC
Journal: Journal of Clinical Epidemiology
Postal address
University Health Network
Toronto General Hospital
200 Elizabeth Street, 9EB-240
Toronto (ON) M5G 2C4
CanHepC's administrative office is situated on the traditional territories of the Mississaugas of the Credit, the Anishnabeg, the Haudenosaunee and the Wendat peoples. Toronto is covered by Treaty 13 with the Mississaugas of the Credit.
© 2025 CanHepC - Canadian Network on Hepatitis C. All Rights Reserved.
